STORY / PUBLIC SOURCE RECORD
Health industry year in review 2025: Norway makes global strides
- Published 12 December 2025; updated 26 August 2026; estimated reading time 3 minutes. The article reviews year two of Norway’s three-year health and life-science export initiative, reporting more international engagement, partnerships and commercial opportunities after the initial year focused on mapping and consolidating the sector.
- Radiopharma: A spring trade mission to Japan, including Expo Osaka, connected Norwegian radiopharma and oncology companies with the Japanese market. Bayer, GE HealthCare and Oslo University Hospital participated alongside Agilera and the Norwegian Medical Cyclotron Centre. The article says the programme created strategic exposure and illustrated benefits of a unified Norwegian presence.
- International outreach included JPMorgan Healthcare Conference and BIO International Convention in the US, DMEA in Germany, NHS Confederation in the UK and Nordic Life Science Days in Sweden. A German-Norwegian health agreement brought digital-health providers together with Berlin’s Charité. Norwegian military medicine and clinical AI were presented at a US-Norway business summit.
- Partnerships: Mayo Clinic signed an agreement with Dossier Solutions on its digital competence-management platform. Mayo Clinic’s Berg Innovation Exchange signed MoUs with University Hospital of North Norway and UiT, and included Nordic Brain Tech and SynPlan; Innovation Norway agreed to establish a Nordic hub in Norway with the Exchange. The Health Innovation Accelerator continued with Mayo Clinic Berg Innovation Exchange, Innovation Norway and DNB/Back Bay.
- European healthcare access: Sensio received a UK care-home supplier award. DNV Imatis joined a “Silent Hospital” pilot at Royal Cornwall Hospitals NHS Trust; initial results cited by the page report 0.5 fewer postnatal-stay days and GBP 75,000 annual savings. Vitalthings supplied monitoring solutions to four German clinics for workflow/cost-benefit evaluation. Dossier Solutions completed competence-management pilots at University Hospital Bonn and University Medical Centre Göttingen and signed agreements with Laerdal Medical and Singapore’s SingHealth.
- The initiative formed a Norwegian “national team” in 2024 to open markets for the wider sector; the article says Laerdal’s platform has helped smaller firms in the US and Singapore. It cites a Menon Economics report that export growth is mainly driven by pharmaceutical companies while digital health and medical technology are emerging. Plans for 2026 included targeted trade missions, partnerships and investment attraction. The article says 13 health/life-science companies had received the Made in Norway label since its 2024 launch; it names Aidn, Deepinsight, DIPS and Sonett as four certified in 2025.
- Contact: Tone Varslot Stave, Head of the national export initiative on health and life science at Innovation Norway, tone.varslot.stave@innovasjonnorge.no. Related industry: Health and life science.
- Public phone number revealed by the page control on 8 October 2026: +47 952 25 533.